109 related articles for article (PubMed ID: 4591648)
1. [Primary hypertension with low plasma renin level].
Klaus D; Klumpp F; Zehner J
Dtsch Med Wochenschr; 1973 Oct; 98(42):1980-7. PubMed ID: 4591648
[No Abstract] [Full Text] [Related]
2. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
Jose A; Kaplan NM
Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
[No Abstract] [Full Text] [Related]
3. [Is essential hypertension still a disease entity? Definition of hyporeninemic hypertension].
Distler A
Internist (Berl); 1974 Mar; 15(3):146-54. PubMed ID: 4600300
[No Abstract] [Full Text] [Related]
4. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
Hood SJ; Taylor KP; Ashby MJ; Brown MJ
Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
[TBL] [Abstract][Full Text] [Related]
5. [Exchangeable sodium, total-body potassium, plasma volume, and hypotensive effect of various diuretics in patients with essential hypertension and low plasma renin level (author's transl)].
Distler A; Keim HJ; Philipp T; Philippi A; Walter U; Werner E
Dtsch Med Wochenschr; 1974 Apr; 99(17):864-9. PubMed ID: 4834874
[No Abstract] [Full Text] [Related]
6. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
[TBL] [Abstract][Full Text] [Related]
7. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
Espiner EA; Mansfield H; Miles K
N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
[No Abstract] [Full Text] [Related]
8. Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.
Bühler FR; Laragh JH; Baer L; Vaughan ED; Brunner HR
N Engl J Med; 1972 Dec; 287(24):1209-14. PubMed ID: 5084985
[No Abstract] [Full Text] [Related]
9. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
10. [The effect of spironolactone and trichlormethiazide on blood pressure, plasma dry weight and plasma potassium in the elderly hypertension].
Nakada I; Sekimoto H; Nakano T; Shimada O; Horibe N; Fuse N
Nihon Ronen Igakkai Zasshi; 1983 Nov; 20(6):491-9. PubMed ID: 6371331
[No Abstract] [Full Text] [Related]
11. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
Uchida K; Morimoto S; Takeda R; Murakami M
Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
[No Abstract] [Full Text] [Related]
12. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
Mahmud A; Mahgoub M; Hall M; Feely J
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
[TBL] [Abstract][Full Text] [Related]
13. Prolonged alteration of renin responsiveness after spironolactone therapy. A cause of false-negative testing for low-renin hypertension.
Lowder SC; Liddle GW
N Engl J Med; 1974 Dec; 291(23):1243-4. PubMed ID: 4422945
[No Abstract] [Full Text] [Related]
14. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
Kreeft JH; Larochelle P; Ogilvie RI
Can Med Assoc J; 1983 Jan; 128(1):31-4. PubMed ID: 6336600
[TBL] [Abstract][Full Text] [Related]
15. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G
Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of essential hypertension with spironolactone with reference to the plasma renin activity].
Esch I; Placheta P
Wien Klin Wochenschr; 1973 Jun; 85(23):413-7. PubMed ID: 4575841
[No Abstract] [Full Text] [Related]
17. Renin and hypertension: a review article.
Jones J
Cent Afr J Med; 1973 Apr; 19(4):83-4 passim. PubMed ID: 4574459
[No Abstract] [Full Text] [Related]
18. [Relations between hypotensive effect and modifications of volemia and plasma renin activity in patients with essential hypertension treated using spironolactone].
Pessina AC; Corgnati A; Palù CD
Minerva Med; 1977 Feb; 68(8):509-14. PubMed ID: 846681
[TBL] [Abstract][Full Text] [Related]
19. Steroid receptors and hypertension.
Coghlan JP; Butkus A; Denton DA; Graham WF; Humphery TJ; Scoggins BA; Whitworth JA
Circ Res; 1980 Jun; 46(6 Pt 2):I88-93. PubMed ID: 6991153
[No Abstract] [Full Text] [Related]
20. [Primary hypo- and hyperreninism].
Werning C
Internist (Berl); 1974 Mar; 15(3):174-6. PubMed ID: 4365784
[No Abstract] [Full Text] [Related]
[Next] [New Search]
